Provider Network Holdings Appoints Keith Crawford as President
Throughout his career, Keith has held multiple leadership positions within the healthcare sector, demonstrating his ability to drive substantial growth and improve operational efficiencies. Most recently, he served as CarePathRx's President of Specialty Pharmacy & Infusion Solutions which was acquired by Evernorth Health Services, a subsidiary of Cigna. His commitment to enhancing patient outcomes and fostering collaborative relationships aligns seamlessly with Provider Network Holdings' mission to empower independent specialty providers and supply chain stakeholders. "Joining Provider Network Holdings is both an honor and a thrill," said Crawford. "I am excited to work with such a dedicated team focused on delivering innovative solutions that enhance patient care and serve specialty providers. Together, we will continue to build upon PNH's impressive foundation and drive meaningful change across the healthcare landscape."
About Provider Network Holdings
Provider Network Holdings serves a network of over 2,000 provider partners across multiple physician specialties with a comprehensive suite of practice management, supply chain, group purchasing, and pharmaceutical solutions for specialty and biologic drug needs. Proprietary technology, data analytics, and unique clinical positioning enable Provider Network Holdings to create custom programs and breakthrough offerings that address the evolving landscape across specialty providers, pharmaceutical manufacturers, and wholesalers. To learn more, visit www.providernetworkholdings.com.
About Waud Capital Partners
Based in
Provider Network Holdings Contact:
[email protected]
Waud Capital Partners Investment Professional Contact:
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/provider-network-holdings-appoints-keith-crawford-as-president-302633453.html
SOURCE Provider Network Holdings
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lilly to present Alzheimer's disease diagnostic and therapeutic research at AAIC 2026, including new data on P-tau217 blood tests and amyloid-targeting treatment
- Biocon Announces Publication of Pivotal Clinical Data Supporting Effectiveness of Yesafili™, a Biosimilar to Eylea® (Aflibercept)
- Gold Strike Announces Commencement of Drilling at Florin Gold Project, Yukon
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share